Conditional probability of long-term survival after resection of hilar cholangiocarcinoma

被引:39
作者
Buettner, Stefan [1 ]
Margonis, Georgios A. [1 ]
Kim, Yuhree [1 ]
Gani, Faiz [1 ]
Ethun, Cecilia G. [2 ]
Poultsides, George [3 ]
Thuy Tran [3 ]
Idrees, Kamran [4 ]
Isom, Chelsea A. [4 ]
Fields, Ryan C. [5 ]
Krasnick, Bradley [5 ]
Weber, Sharon M. [6 ]
Salem, Ahmed [6 ]
Martin, Robert C. G. [7 ]
Scoggins, Charles R. [7 ]
Shen, Perry [8 ]
Mogal, Harveshp D. [8 ]
Schmidt, Carl [9 ]
Beal, Eliza [9 ]
Hatzaras, Loannis [10 ]
Shenoy, Rivfka [10 ]
Maithel, Shishir K. [2 ]
Pawlik, Timothy M. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Dept Surg, Baltimore, MD 21287 USA
[2] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
[3] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA
[4] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA
[5] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[6] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA
[7] Univ Louisville, Dept Surg, Louisville, KY 40292 USA
[8] Wake Forest Univ, Dept Surg, Winston Salem, NC 27109 USA
[9] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[10] NYU, Dept Surg, New York, NY 10016 USA
关键词
DISEASE-FREE SURVIVAL; PERIHILAR CHOLANGIOCARCINOMA; MULTIINSTITUTIONAL ANALYSIS; SURGICAL RESECTION; HEPATIC RESECTION; STAGING SYSTEM; CANCER; LIVER; MALIGNANCIES; CARCINOMA;
D O I
10.1016/j.hpb.2016.04.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: While traditional survival analyses focus on factors determined at the time of surgery, conditional survival (CS) estimates prognosis relative to time following treatment. We sought to compare actuarial and CS among patients undergoing curative intent surgery for hilar cholangiocarcinoma. Methods: 242 patients undergoing surgery between 2000 and 2014 were identified using a multi institutional database. CS was calculated as the probability of surviving an additional 3 years, given that the patient had already survived "x" years from surgery. Results: Median patient age was 67 years (IQR: 57-73) and most patients were male (n = 140, 57.9%). Lymph node metastases were noted in 79 (32.6%) patients while an RO margin was obtained in 66.1% (n = 160). Median OS was 22.3 months. Actuarial survival decreased over time from 46.3% at 2 years following surgery to 18.2% at 5 years; in contrast, the 3-year CS (CS3) increased with time (CS3 at 2 years was 39.3% versus 54.4% at 5 years). CS3 exceeded actuarial survival for high-risk patients with patients with perineural invasion demonstrating an actuarial survival of 15.4% at 5 years versus CS3 of 37.6% at 2 years following surgery (Delta = 22.2%). Conclusions: CS provides a more accurate, dynamic estimate for survival, especially among high-risk patients.
引用
收藏
页码:510 / 517
页数:8
相关论文
共 19 条
  • [1] Conditional Disease-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors A Multi-institutional Analysis of 502 Patients
    Bischof, Danielle A.
    Kim, Yuhree
    Dodson, Rebecca
    Jimenez, M. Carolina
    Behman, Ramy
    Cocieru, Andrei
    Fisher, Sarah B.
    Groeschl, Ryan T.
    Squires, Malcolm H., III
    Maithel, Shishir K.
    Blazer, Dan G., III
    Kooby, David A.
    Gamblin, T. Clark
    Bauer, Todd W.
    Quereshy, Fayez A.
    Karanicolas, Paul J.
    Law, Calvin H. L.
    Pawlik, Timothy M.
    [J]. JAMA SURGERY, 2015, 150 (04) : 299 - 306
  • [2] BISMUTH H, 1975, SURG GYNECOL OBSTET, V140, P170
  • [3] Burke EC, 1998, ANN SURG, V228, P385, DOI 10.1097/00000658-199809000-00011
  • [4] A New Clinically Based Staging System for Perihilar Cholangiocarcinoma
    Chaiteerakij, Roongruedee
    Harmsen, William S.
    Marrero, Carlos Romero
    Aboelsoud, Mohammed M.
    Ndzengue, Albert
    Kaiya, Joseph
    Therneau, Terry M.
    Sanchez, William
    Gores, Gregory J.
    Roberts, Lewis R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (12) : 1881 - 1890
  • [5] Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients
    Cucchetti, Alessandro
    Piscaglia, Fabio
    Cescon, Matteo
    Ercolani, Giorgio
    Terzi, Eleonora
    Bolondi, Luigi
    Zanello, Matteo
    Pinna, Antonio D.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4397 - 4405
  • [6] Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
    DeOliveira, Michelle L.
    Cunningham, Steven C.
    Cameron, John L.
    Kamangar, Farin
    Winter, Jordan M.
    Lillemoe, Keith D.
    Choti, Michael C.
    Yeo, Charles J.
    Schulick, Richard D.
    [J]. ANNALS OF SURGERY, 2007, 245 (05) : 755 - 762
  • [7] Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma
    Jarnagin, WR
    Fong, Y
    DeMatteo, RP
    Gonen, M
    Burke, EC
    Bodniewicz, J
    Youssef, M
    Klimstra, D
    Blumgart, LH
    [J]. ANNALS OF SURGERY, 2001, 234 (04) : 507 - 517
  • [8] Conditional Survival after Surgical Resection of Gastric Cancer: A Multi-Institutional Analysis of the US Gastric Cancer Collaborative
    Kim, Yuhree
    Ejaz, Aslam
    Spolverato, Gaya
    Squires, Malcolm H.
    Poultsides, George
    Fields, Ryan C.
    Bloomston, Mark
    Weber, Sharon M.
    Votanopoulos, Konstantinos
    Acher, Alexandra W.
    Jin, Linda X.
    Hawkins, William G.
    Schmidt, Carl
    Kooby, David
    Worhunsky, David
    Saunders, Neil
    Cho, Clifford S.
    Levine, Edward A.
    Maithel, Shishir K.
    Pawlik, Timothy M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (02) : 557 - 564
  • [9] Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram
    Koerkamp, B. Groot
    Wiggers, J. K.
    Gonen, M.
    Doussot, A.
    Allen, P. J.
    Besselink, M. G. H.
    Blumgart, L. H.
    Busch, O. R. C.
    D'Angelica, M. I.
    DeMatteo, R. P.
    Gouma, D. J.
    Kingham, T. P.
    van Gulik, T. M.
    Jarnagin, W. R.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (09) : 1930 - 1935
  • [10] Prognosis and Conditional Disease-Free Survival Among Patients With Ovarian Cancer
    Kurta, Michelle L.
    Edwards, Robert P.
    Moysich, Kirsten B.
    McDonough, Kathleen
    Bertolet, Marnie
    Weissfeld, Joel L.
    Catov, Janet M.
    Modugno, Francesmary
    Bunker, Clareann H.
    Ness, Roberta B.
    Diergaarde, Brenda
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4102 - U327